| Name | 3-[(3,4-dichlorophenyl)methyl]-2-methyl-N-pentylsulfonylbenzimidazole-5-carboxamide |
|---|---|
| Synonyms |
1H-Benzimidazole-6-carboxamide,1-((3,4-dichlorophenyl)methyl)-2-methyl-N-(pentylsulfonyl)
UNII-99G2WZ2U4V |
| Description | FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1. FR-229934 can be used for the research of pulmonary arterial hypertension and erectile dysfunction[1]. |
|---|---|
| Related Catalog | |
| Target |
PDE V |
| References |
[1]. PANDYA J, et, al. Liquid oral formulations for pde v inhibitors. WO2019130052A1. |
| Molecular Formula | C21H23Cl2N3O3S |
|---|---|
| Molecular Weight | 468.39700 |
| Exact Mass | 467.08400 |
| PSA | 92.93000 |
| LogP | 6.60520 |